renal deficient diet
The use of parenteral iron therapy has increased rapidly among patients with chronic kidney disease (CKD). This may be so for several potential reasons: First, it is now well established that in patients on hemodialysis requiring recombinant human ...
Read more
Iron Therapy in CKD Patients -- Harm or Benefit? - Medscape News
SOUTH SAN FRANCISCO, Calif., Oct. 23 /PRNewswire/ -- Hyperion Therapeutics, Inc. today announced that the first patient has been enrolled in a Phase 1/2 clinical trial of Glyceryl Tri (4-Phenylbutyrate) (GT4P) in patients with urea cycle disorders ...
Read more
Hyperion Therapeutics Announces Enrollment of First Patient in Phase 1 ... - PR Newswire
Read more